Low hemoglobin, chronic kidney disease, and risk for coronary heart disease-related death: the Blue Mountains Eye

Stephen R Leeder1, Paul Mitchell, Gerald Liew

  • 1The Australian Health Policy Institute, College of Health Sciences, University of Sydney, Westmead Hospital, Hawkesbury Road, Westmead, NSW Australia, 2145.

Insights

Chronic kidney disease (CKD) combined with low hemoglobin, even within normal ranges, significantly elevates the risk of coronary heart disease (CHD) death. This increased risk was not observed in individuals without CKD.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Previous research indicated a link between chronic kidney disease (CKD) and increased coronary heart disease (CHD) risk, particularly in individuals with anemia.
  • The Blue Mountains Eye Study cohort provided an opportunity to prospectively investigate this association in an Australian population.

Purpose of the Study:

  • To verify the hypothesis that CKD exacerbates CHD risk specifically in individuals with low hemoglobin levels.
  • To examine the interaction between estimated glomerular filtration rate (eGFR) and hemoglobin levels concerning CHD-related mortality.

Main Methods:

  • A prospective cohort study of 3654 Australian adults aged 49-97 years.
  • Fasting blood samples were collected, and CHD-related deaths were tracked over 9 years using the Australian National Death Index.
  • CKD was defined as eGFR <60 ml/min/1.73 m² (Cockcroft-Gault equation), and low hemoglobin was defined as levels in the lowest quintile.

Main Results:

  • Individuals with CKD and low hemoglobin exhibited a significantly increased risk of CHD-related death (HR 1.49; 95% CI 1.08-2.06) compared to those with CKD and higher hemoglobin.
  • This heightened risk associated with low hemoglobin was specific to the CKD group and not observed in individuals without CKD.
  • A significant interaction between eGFR and hemoglobin was found when using the Cockcroft-Gault or Bjornsson equations for eGFR estimation.

Conclusions:

  • The presence of CKD, particularly when accompanied by low hemoglobin levels (even within the normal range), is associated with an elevated risk of CHD-related mortality.
  • These findings underscore the importance of considering hemoglobin status in the cardiovascular risk assessment of patients with CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...